meddevicedb.com FDA Device Reference

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement

K260536 Class II Traditional
Decision Date
2026-05-15
Sponsor / Applicant
Depuy Ireland UC

Technical Specification

510(k) Submission ID K260536
Product Code KWL
Medical Specialty / Panel Orthopedic
Regulation Citation 21 CFR 888.3360
Decision Date 2026-05-15
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement received FDA 510(k) clearance under submission number K260536, sponsored by Depuy Ireland UC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2026-05-15.

Classification & Regulation

This clearance is catalogued under FDA product code KWL and 21 CFR 888.3360, within the Orthopedic review panel as a Class II device.